[The human papillomavirus vaccine: is it of value in dermatology?]

Actas Dermosifiliogr. 2012 Mar;103(2):92-3. doi: 10.1016/j.ad.2011.11.007. Epub 2012 Jan 30.

[Article in Spanish]

Authors

R Pedragosa-Jové¹, M Salleras-Redonet; Miembros fundadores del Grupo de trabajo de Epidemiología y Prevención de la Salud en Dermatología

Affiliation

¹ Servicio de Dermatología, Hospital Plató, Barcelona, España. [email protected]

PMID: 22296714
DOI: 10.1016/j.ad.2011.11.007

No abstract available

Publication types

Editorial

MeSH terms

Adolescent
Adult
Anus Neoplasms / epidemiology
Anus Neoplasms / etiology
Anus Neoplasms / prevention & control
Anus Neoplasms / virology
Carcinoma / epidemiology
Carcinoma / etiology
Carcinoma / prevention & control
Carcinoma / virology
Child
Condylomata Acuminata / epidemiology
Condylomata Acuminata / etiology
Condylomata Acuminata / prevention & control
Dermatology / trends
Female
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Human papillomavirus 16 / pathogenicity
Human papillomavirus 18 / pathogenicity
Humans
Male
Middle Aged
Mouth Neoplasms / epidemiology
Mouth Neoplasms / etiology
Mouth Neoplasms / prevention & control
Mouth Neoplasms / virology
Papillomavirus Infections / complications
Papillomavirus Infections / epidemiology
Papillomavirus Infections / prevention & control*
Papillomavirus Vaccines*
Penile Neoplasms / epidemiology
Penile Neoplasms / etiology
Penile Neoplasms / prevention & control
Penile Neoplasms / virology
Spain / epidemiology
Tumor Virus Infections / complications
Tumor Virus Infections / epidemiology
Tumor Virus Infections / prevention & control*
Young Adult

Substances

Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
Papillomavirus Vaccines
human papillomavirus vaccine, L1 type 16, 18